Go To Exhibition The 6th Life Science & Technology Week, Biomed, Tel Aviv, Israel, June 5-7, 2007

Final Program - International Stem Cell Meeting

• Day 1 - Tuesday, June 05, 2007
 
• Day 2 - Wednesday, June 06, 2007
 
• Day 3 - Thursday, June 07, 2007
 

Tuesday, June 05, 2007

09:00 - 09:30 David Intercontinental - Hall B
OPENING CEREMONY
Chairperson:  Rafi Hofstein
09:00 WELCOME
E. Yishai 1, R. Alon 2, D. Zajfman 3, S. Mor-Yosef 4
1 Minister Of Industry, Trade And Labor, Israel; 2 Chairperson, ILSI (Israel LIfe Science Industry); 3 President, The Weizmann Institute Of Science, Israel; 4 Hospital Director, Hadassah University Hospital And Hebrew University School Of Medicine, Israel
09:30 - 10:15 David Intercontinental - Hall B
KEYNOTE LECTURE
Chairperson:  Dov Zipori
09:30 NORMAL AND NEOPLASTIC STEM CELLS
I.L. Weissman
1 Stanford University School Of Medicine, California, USA
10:15 COFFEE BREAK
10:45 - 12:45 Dan Panorama - Hall E
PLENARY SESSION I: THE STEM CELL AND ITS MICROENVIRONMENT
Invited Lectures
Chairpersons:   Yair Reisner
  Yehudit Bergman
10:45 THERAPEUTIC MANIPULATION OF THE STEM CELL NICHE
D.T. Scadden 1
1 Stem Cell Institute, Harvard Medical School, Boston, MA, USA
11:25 WNT AND NOTCH COOPERATE TO MAINTAIN PROLIFERATIVE COMPARTMENTS IN CRYPTS
H. Clevers
1 Hubrecht Laboratory, Utrecht, The Netherlands
12:05 REGULATION OF STEM CELL HOMING AND MOBILIZATION
T. Lapidot 1
1 Weizmann Institute Of Science, Rehovot, Israel
12:25 DIALOG BETWEEN NEURAL ADULT STEM CELLS AND IMMUNE SYSTEM IN HEALTH AND DISEASE
M. Schwartz 1
1 Weizmann Institute Of Science, Rehovot, Israel
12:45 LUNCH BREAK
14:15 - 16:15 Dan Panorama - Hall E
SESSION 1A: EMBRYONIC STEM CELLS
Chairpersons:   Daniel Aberdam
  Varda Rotter
14:15 INVITED LECTURE: LINEAGE SPECIFIC DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
N. Benvenisty 1
1 Hebrew University Of Jerusalem, Jerusalem, Israel
14:35 PLURIPOTENCY- AND DIFFERENTIATION-ASSOCIATED GENE AND MICRORNA EXPRESSION MODULES IDENTIFIED IN KINETIC PROFILES OF HUMAN EMBRYONIC STEM CELL DIFFERENTIATION
Y. Soen 1, E. Chiao 2, J. Baker 2, P.O. Brown 3
1 Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel; 2 Department of Genetics, Stanford University, Stanford, CA, USA; 3 Department of Biochemistry, Stanford University, Stanford, CA, USA
14:55 MAPPING THE HIERARCHY OF HUMAN EMBRYONIC STEM CELL-DERIVED LINEAGES
M. Drukker 1, P.O. Brown 2, I.L. Weissman 1, Y. Soen 3
1 Departments of Pathology and Developmental Biology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, CA 94305, USA; 2 Department of Biochemistry and Howard Hughes Medical Institute, Stanford, CA 94305, USA; 3 Department of Biological Chemistry, Ullman Building, Weizmann Institute of Science 76100 Rehovot, Israel.
15:15 IMPORTANT ROLE OF A CELL-TYPE-SPECIFIC TAF IN EMBRYONIC STEM CELL PLURIPOTENCY AND SELF-RENEWAL
R. Kedmi 1, S. Moshonov 1, I. Lax 1, R. Dikstein 1
1 Dept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel
15:35 KEY ROLE OF DNP63 IN ECTODERMAL STEM CELL PROLIFERATION AND EPIDERMAL COMMITMENT OF EMBRYONIC STEM CELLS
P. Rostagno 1, A. Medawar 1, E. Aberdam 1, M. Rouleau 1, D. Aberdam 1,2
1 Inserm, Nice, France; 2 Insertech Technion, Haifa, Israel
15:55 SUSPENDED CULTURE OF UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS
M. Amit 1,3, J. Chebath 2, V. Marguletz 1, M. Peri 1, I. Laevsky 1, Y. Mirupolsky 1, K. Shariki 1, M. Revel 2, J. Itskovitz-Eldor 1
1 Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa; 2 Department of Molecular Genetics, Weizmann Institute of Science, Rehovot; 3 The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa
16:15 COFFEE BREAK
14:15 - 16:15 Dan Panorama - Hall F
SESSION 1B: HEMATOPOIETIC STEM CELLS
Chairpersons:   Eliezer Rachmilewitz
  Arnon Nagler
14:15 P53 TUMOR SUPPRESSOR REGULATES HUMAN HEMATOPOIETIC STEM CELLS (HHSC) SELF-RENEWAL AND SURVIVAL.
M. Milyavsky 1, O.I. Gan 1, E. Lechman 1, F. Notta 1, J.E. Dick 1
1 Molecular Cell Biology, University Health Network, Toronto, Canada
14:35 A NOVEL MDR-DEPENDENT APPROACH FOR EX-VIVO EXPANSION OF HEMATOPOIETIC STEM CELLS (HSCS) FROM HUMAN UMBILICAL CORD BLOOD (HUCB) FOR TRANSPLANTATION
A. Nagler 1, I. Bar 1, H. Galski 1
1 Hematology Division, Chaim sheba Medical Center, Tel Hashomer, Israel
14:55 FAS-LIGAND ENHANCES HEMATOPOIETIC CELL ENGRAFTMENT THROUGH ABROGATION OF ALLOIMMUNE RESPONSES AND NON-IMMUNOGENIC FUNCTIONS
I. Yaniv 1, J. Stein 1, M. Pearl-Yafe 2, A. Kaminitz 2, E.S. Yolcu 3, H. Shirwan 3, N. Askenasy 2
1 Department Of Pediatric Hematology-Oncology, Schneider Children’s Medical Center Of Israel, Petach Tikva, Israel; 2 Frankel Laboratory, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel; 3 Department of Microbiology and Immunology, University of Louisville, Louisville, KY, USA
15:15 UNIQUE PATTERN OF HEMATOPOIETIC CELL MOBILIZATION INDUCED BY THE CXCR4 ANTAGONIST 4F-BENZOYL-TN14003
M. Abraham 1, K. Beyder 1, M. Begin 1, H. Wald 1, I. Wiss 1, E. Galun 1, A. Nagler 2, A. Peled 1
1 Goldyne Savad Institute Of Gene Therapy, Hadassah University Hospital, Jerusalem; 2 Bone Marrow Transplantation Department, Chaim Sheba Medical Center, Tel-Hashomer, Israel
15:35 THE TYROSINE KINASE C-MET PROMOTES PROGENITOR CELL MOBILIZATION BY INDUCING DYNAMIC CHANGES IN THE ENDOSTEAL REGION
M. Tesio 1,2, A. Kalinkovich 1, S. Giordano 3, E. Buss 1, A. Schajnovitz 1, T. Itkin 1, A Dar 1, O. Kollet 1, I. Petit 1, M. Aglietta 2, W. Piacibello 2, T. Lapidot 1
1 Immunology DEpartment, WEizmann Institute of Science, Rehovot, Israel; 2 Laboratory of Clinical Oncology, Institute for Cancer Research and Treatment, University of Turin Medical School, 10060 Candiolo, Italy; 3 Division of Molecular Oncology, Institute for Cancer Research and Treatment, University of Turin Medical School, 10060 Candiolo, Italy
15:55 A FUNCTIONAL QUORUM SENSING MECHANISM AND HIGH INTER STEM CELL SIGNALING ARE NECESSARY AND SUFFICIENT PREREQUISITES FOR NORMAL TISSUE DEVELOPMENT: ANALYSIS OF A MATHEMATICAL MODEL YIELDING FORMULAE FOR CELLULAR TISSUE COMPOSITION AT ANY GIVEN TIME
Z. Agur, O.U. Kirnasovsky, L. Levi
1 Institute For Medical BioMathematics, Bene Ataroth, Israel
16:15 COFFEE BREAK
16:45 - 18:05 Dan Panorama - Hall E
PLENARY SESSION II: EMBRYONIC STEM CELLS
Invited Lectures
Chairpersons:   Nissim Benvenisty
  Dina Ben Yehuda
16:45 TAMING HUMAN EMBRYONIC STEM CELLS AND TURNING THEM INTO HEART AND DIABETES CELL THERAPIES
A. Colman 1
1 ES Cell International Pte Ltd, Singapore
17:25 EMBRYONIC PIG PRECURSOR TISSUES AS A NEW SOURCE FOR ORGAN TRANSPLANTATION: THE CHOICE BETWEEN TERATOMA, NORMAL GROWTH AND IMMUNOGENICTY
Y. Reisner 1
1 Immunology, Weizmann Institute of Science, Rehovot, Israel
17:45 NEURAL DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS (HESCS) - MECHANISMS AND POTENTIAL APPLICATIONS
B. Reubinoff 1
1 The Hadassah Human Embryonic Stem Cell Research Center, Hadassah Medical Center Of The Hebrew University, Jerusalem, Israel

Back to top

 

Wednesday, June 06, 2007

09:00 - 10:20 Dan Panorama - Hall E
PLENARY SESSION III: FROM DROSOPHILA TO ADULT MAMMALIAN STEM CELLS
Invited Lectures
Chairpersons:   Benny Shilo
  Jerry Stein
09:00 INTERACTIONS BETWEEN GERMLINE STEM CELLS AND THEIR NICHE
T. Xie 1
1 Stowers Institute For Medical Research, Kansas City, MO 64110, USA
09:40 MULTIPOTENT STROMAL CELLS (MSCS) FROM BONE MARROW AS AGENTS OF TISSUE REPAIR
D. J. Prockop 1
1 Center for Gene Therapy, Tulane University Health Sciences Center, New Orleans, USA
10:20 COFFEE BREAK
10:50 - 12:50 Dan Panorama - Hall E
SESSION 2A: MESENCHYMAL STEM CELLS
Chairpersons:   Dan Gazit
  Ronen Alon
10:50 INVITED LECTURE: GENETICALLY MODIFIED STEM CELLS AS A PLATFORM FOR SKELETAL REGENERATIVE MEDICINE
D. Gazit 1
1 Skeletal Biotech Laboratory, Hebrew University - Hadassah Medical Campus, Jerusalem, Israel.
11:10 INSIGHT INTO THE IDENTIFICATION OF MESENCHYMAL STEM CELLS
D. Benayahu 1
1 Dep of Cell and Developmental Biology, Sackler School of Medicin, Tel Aviv University
11:30 BONE MARROW MESENCHYMAL STEM CELLS ARE LINEAGE-PRIMED TO A RESTRICTED NUMBER OF MESODERMIC GENETIC PROGRAMS
B. Delorme 1, J. Ringe 2, C. Jorgensen 3, T. Hauepl 2, P. Charbord 1
1 INSERM-ESPRI/EA-3855, Tours, France; 2 Charite, Berlin, Germany; 3 INSERM U475, Montpellier, France
11:50 TISSUE ENGINEERING OF HIGH QUALITY CARTILAGE FROM OSTEOARTHRITIC BONE MARROW STEM CELLS
A.P. Hollander 1, W.Z. Kafiena 1, S. Mistry 1, S.C. Dickinson 1, T.J. Sims 1, M.J. Perry 1
1 University of Bristol Academic Rheumatology, Southmead Hospital, Bristol, UK
12:10 DIFFERENTIATED HUMAN BONE MARROW STEM CELLS WITH ENHANCED PRODUCTION OF NEUROTROPHIC FACTORS AMELIORATE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
D. Offen 1, S. Gai-Castro 1, Y. Barhum 1, M. Bahat-Stromza 1, E. Melamed 1
1 Laboratory of Neurosciences, Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel
12:30 FIBRIN MICROBEADS (FMB): A SINGLE MATRIX FOR HIGH YIELD ISOLATION, EXPANSION, DIFFERENTIATION AND CARRIERS FOR IMPLANT OF ADULT PROGENITOR CELLS FOR TISSUE REGENERATION
R. Gorodetsky 1,2, R. Rivkin 1, I. Kassis 1, A. Ben-Ari 1, L. Levdansky 1, E. Gaberman 1, G. Marx 2
1 Lab. of Biotechnology and Radiobiology, Sharett Institute, Hadassah Medical Organization, Jerusalem , Israel; 2 Hapto Biotech, Israel
12:50 LUNCH BREAK
10:50 - 12:50 Dan Panorama - Hall F
SESSION 2B: STEM CELL AND THERAPEUTIC PROSPECTS
Chairpersons:   Ronald S. Goldstein
  Nadir Askenasy
10:50 GENERATION OF NEURAL CREST AND PERIPHERAL NEURON-LIKE CELLS FROM HUMAN EMBRYONIC STEM CELLS
R.S. Goldstein 1
1 Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
11:10 THE REGULATORY FUNCTIONS “DEATH RECEPTORS” IN HEMATOPOIESIS
I. Yaniv 1, M. Pearl-Yafe 2, O. Kaplan 3, J. Stein 1, N. Askenasy 2
1 Department Of Pediatric Hematology-Oncology, Schneider Hospital; 2 Frankel Laboratory, Schneider Children’s Medical Center; 3 Department of Surgery, Sackler School of Medicine, Tel Aviv University
11:30 THE HUMAN CORNEA: A MODEL FOR THE STUDY OF THE BIOLOGY AND THERAPEUTIC POTENTIAL OF STEM CELLS
J.T. Daniels 1
1 Ocular Repair and Regeneration Biology Unit (ORB), UCL Institute of Ophthalmology, London, UK
11:50 SIMPLIFYING THE CLINICAL DELIVERY OF CULTURED AUTOLOGOUS SKIN CELLS FOR BURNS AND CHRONIC WOUNDS
S. MacNeil 1
1 University of Sheffield, Sheffield, South Yorkshire, UK
12:10 REGENERATION AND TRANS-DIFFERENTIATION POTENTIAL OF MUSCLE PROGENITOR CELLS
R. Sarig, O. Fuchs, Z. Baruchi, U. Nudel, D. Yaffe
1 Department Of Molecular Cell Biology, Weizmann Institute Of Science, Rehovot, Israel
12:30 ANALYSIS OF BETA 1-INTEGRINS AND CHEMOKINE RECEPTORS EXPRESSED BY ADULT NEURAL STEM CELLS THAT AMELIORATE AUTOIMMUNE ENCEPHALOMYELITIS (EAE) AND SUPPRESS AUTOREACTIVE T CELLS
R. Zilkha-Falb 1, N. Kaushansky 1, A. Ben-Nun 1
1 Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
12:50 LUNCH BREAK
14:00 - 15:00 Dan Panorama - Hall E
SESSION 3A: MYOGENIC STEM CELLS
Chairpersons:   Jonathan Leor
  David Yaffe
14:00 INVITED LECTURE: THE SCIENCE AND FICTION OF MYOCARDIAL REGENERATION
J. Leor 1
1 Tel-Aviv University, Sheba Medical Center
14:20 HOW THE WNT/B-CATENIN PATHWAY REGULATES CARDIAC AND SKELETAL MUSCLE PROGENITORS ?
E. Nathan, A. Monovich, T. Rousso, C. Bar, L. Tirosh-Finkel, E. Tzahor
1 Department Of Biological Regulation, Weizmann Institute Of Science, Rehovot, Israel
14:40 ENGINEERING VASCULARIZED CARDIAC MUSCLE TISSUE FROM HUMAN EMBRYONIC STEM CELLS
A. Lesman 1, O. Caspi 2, Y. Bashevitch 1, A. Gepstein 2, G. Arbel 2, I. Huber 2, M. Habib 2, L. Gepstein 2, S. Levenberg 1
1 The Department of Biomedical Engineering, Technion Haifa, Israel; 2 The Department of Medicine, Technion Haifa, Israel; 3 Biotechnology Interdisciplinary Unit, Technion Haifa, Israel; 4 Cardiology Department, Rambam Medical Center, Haifa, Israel
14:00 - 15:00 Dan Panorama - Hall F
SESSION 3B: FROM MAMMALIAN STEM CELLS TO CHORDATE STEM CELLS
Chairpersons:   Dafna Benayahu
  Daniel Offen
14:00 DIFFERENTIATION OF DOPAMINERGIC NEURONS IN ZEBRAFISH EMBRYOS
J. Blechman 1, T. Borodovsky 1, M. Eisenberg 1, A. Gutnick 1, H. Nabel-Rosen 1, T. Ponomaryov 1, N. Russek-Blum 1, G. Levkowitz 1
1 Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
14:20 DEVELOPMENTAL REPROGRAMMING AFTER CHROMOSOME TRANSFER INTO MITOTIC MOUSE ZYGOTES
D. Egli 1, J. Rosains 1, G. Birkhoff 1, K. Eggan 1
1 Department Of Molecular And Cellular Biology, Harvard University, Cambridge USA
14:40 IDENTIFICATION OF THE ENDOSTYLE AS A STEM CELL NICHE IN THE COLONIAL CHORDATE BOTRYLLUS SCHLOSSERI
A. Voskoboynik 1, Y. Soen 2, Y. Rinkevich 4, A. Rosner 3, R. Reshef 4, B. Rinkevich 3, K.J Ishizuka 1, K.J. Palmeri 1, I.L. Weissman 1
1 Department of Phatology, Stanford University School of Medicine, Stanford, California, USA; 2 Department of Biochemistry, Stanford University School of Medicine, Stanford, California, USA; 3 Department of Biology, National Institute of Oceanography, Haifa, Israel; 4 Department of Biology, Technion-Israel Institute of technology, Haifa, Israel
15:00 No Room Allocated
POSTER SESSION, COFFEE AND AWARDS FOR BEST POSTERS


16:00 - 17:40 Dan Panorama - Hall F
PLENARY SESSION IV: HEMOPOIETIC AND CARDIOMYOGENIC STEM CELLS
Invited Lectures
Chairpersons:   Eithan Galun
  Benny Geiger
16:00 REDESIGNING SPECIALIZED CELLS
T. Graf 1
1 CRG, Barcelona, Spain
16:40 COMPLEXITY OF THE HUMAN HEMATOPOIETIC STEM CELL COMPARTMENT
D. Bonnet 1
1 Haematopoietic Stem Cell Lab/ Cancer Research UK, London Research Institute, London, UK
17:20 CELL THERAPY FOR HEART DISEASE
L. Gepstein 1
1 The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
17:40 EXHIBITION
18:30 - 19:00 David Intercontinental - Hall B
RAD BIOMED AWARD CEREMONY




19:15 - 22:00 Dan Panorama - Hall E
ILSI GALA EVENING


Back to top

 

Thursday, June 07, 2007

09:00 - 10:20 Dan Panorama - Hall E
PLENARY SESSION V: EMBRYONIC STEM CELLS AND TUMOR INITIATING CELLS
Invited Lectures
Chairpersons:   Chaim Cedar
  Nechama Haran-Ghera
09:00 REGULATION OF THE GROWTH AND SURVIVAL OF EMBRYONIC STEM CELLS
H.E. Broxmeyer 1,2, M.K. Han 3, C. Mantel 1
1 Walther Oncology Center and the Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA; 2 Walther Cancer Institute, Indianapolis, IN, USA; 3 Department of Microbiology and Immunology, Chonbuk National University Medical School, Jeonju, Korea
09:40 CANCER-INITIATING CELLS: FROM LEUKEMIA TO SOLID TUMORS
J. E. Dick 1
1 Dept of Molecular Genetics and Microbiology, University of Toronto, Canada
10:20 COFFEE BREAK
10:50 - 12:50 Dan Panorama - Hall E
SESSION 4A: EMBRYONIC, TUMOR AND PLANT STEM CELLS
Chairpersons:   Joseph Itskovitz-Eldor
  Bracha Rager
10:50 INVITED LECTURE: DERIVATION AND CULTURE OF HUMAN EMBRYONIC STEM CELLS IN DEFINED CONDITIONS
J. Itskovitz-Eldor
1 Dept. Of Obstetrics And Gynecology, Rambam Medical Center, Stem Cell Center, Faculty Of Medicine, Technion Israel
11:10 INVITED LECTURE: RNA EDITING IN HUMAN STEM CELLS AND DEVELOPMENT
R. Shtrichman 1, S. Osenberg 1, M. Safran 2, R. Mandel 3, N. Paz 2, A. Ziskind 1, I. Nahor 1, N. Amariglio 2, J. Itskovitz-Eldor 1, G. Rechavi 2
1 Stem Cell Center, Faculty Of Medicine, Technion, Haifa; 2 Cancer Research Center, Sheba Medical Center, Tel Hashomer And Sackler School Of Medicine, Tel Aviv University; 3 Department Of Obstetrics And Gynecology, Rambam Health Care Campus, Haifa, Israel Department Of Obstetrics And Gynecology, Rambam Health Care Campus, Haifa Israel
11:30 THERAPEUTIC AND RESEARCH POTENTIAL OF HUMAN STEM CELLS
S. L. Minger 1
1 Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, Kings College London, London, United Kingdom
11:50 THE CD44+ FRACTION OF CARCINOMA CELLS SPENDS AN EXTENDED TIME IN THE G2 PHASE OF THE CELL CYCLE.
L.J. Harper 1, D.E. Costea 1, I.C. Mackenzie 1
1 Institute of Cell and Molecular Science, Queen Mary University of London, London, UK
12:10 DEDIFFERENTIATION INDUCES TELOMERASE-INDEPENDENT TELOMERE LENGTHENING IN ARABIDOPSIS
G. Grafi 1, H. Ben-Meir 2, Y. Avivi 2, Y. Dahan 3, M Moshe 2, A. Zemach 2
1 Albert Katz Department of Dryland Biotechnologies, Jacob Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sede Boqer Campus 84990, Israel; 2 Department of Plant Sciences, The Weizmann Institute of Science, Rehovot 76100 Israel; 3 Institute of Plant sciences, ARO, The Volcani Center, Bet-Dagan 50250 Israel
12:30 THE HUMAN EMBRYONIC STEM CELL-DERIVED MICROENVIRONMENT HAS THE POTENTIAL TO UNVEIL CANCER CELL SUB-POPULATIONS THAT DO NOT DEVELOP INTO TUMORS IN CONVENTIONAL MURINE XENOGRAFTS.
E. Katz 1, K. Skorecki 1, M. Tzukerman 1
1 Rambam Health Care Campus, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel.
12:50 LUNCH BREAK
10:50 - 12:50 Dan Panorama - Hall F
SESSION 4B: STEM CELL EXPANSION
Chairpersons:   David Givol
  Edna Mozes
10:50 HUMAN TISSUE ENGINEERING WITH CORD BLOOD STEM CELLS.
C. P. McGuckin 1
1 North East England Stem Cell Institute and Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK
11:10 HUMAN CB-CD.133+ CELLS INJECTED INTO NOD-SCID MICE MADE DEAF AFTER OTOTOXIC TREATMENT PROVIDE CONDITIONS FOR THE RESUMPTION OF THE INNER EAR STRUCTURE AND FUNCTION
R. P. Revoltella 1, S. Papini 1, A. Rosellini 1, M. Michelini 1, A. Martini 2, A. Ciorba 2, L. Bertolaso 2, S. Magosso 2, R. Poulsom 3, R. Jeffery 3
1 Institute of Biomedical Technologies, Immunobiology and Cell Differentiation Unit /CNR, Pisa, Italy.; 2 Dept. Audiology, University Hospital, Ferrara, Italy; 3 Cancer Research UK, London, UK
11:30 HUMAN BONE MARROW STEM CELLS AND BIODEGRADABLE 3D SCAFFOLD FOR BONE TISSUE ENGINEERING
E. Livne 1, T. Kizhner 1, P. Schenzer 1, E. Levy 1, D. Ben David 1, J. Zavin 1, S. Srouji 1
1 Department of Anatomy and Cell Biology, Faculty of Medicine, Technion, Haifa, Israel; 2 Oral and Maxillofacial Surgery, Carmel Medical Center, Haifa, Israel
11:50 ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD HEMATOPOIETIC STEM CELLS (HSC) AND MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
V.R. Deutsch 1, E. Hubel 1, S. Kay 1, B. Katz 1, A. Many 2, D. Grisaru 2, E. Naparstek 1
1 Hematology and bone Marrow transplant, Tel Aviv Medical Center Tel Aviv Israel; 2 Obstetrics and Gynecology, Tel Aviv Medical Center, Tel Aviv Israel
12:10 NICOTINAMIDE, AN INHIBITOR OF NAD(+)-DEPENDENT ADP-RIBOSYL TRANSFERASES, STIMULATES EXPANSION, HOMING AND ENGRAFTMENT OF CYTOKINE-CULTURED CORD BLOOD DERIVED CD34+ CELLS
T. Peled 1, S. Adi 1, I. Peleg 1, N. Rosenheimer 1, H. Shoham 1, Y. Daniely 1, A. Nagler 2, I. Weiss 3, E. Fibach 4, A. Peled 3
1 Gamida Cell Ltd., Jerusalem, Israel; 2 Hematology and CBB Chaim Sheba Medical Center, Tel-Hashomer, Israel; 3 Gene Therapy Institute Hadassah - Hebrew University Medical Center, Jerusalem, Israel; 4 Department of Hematology Hadassah - Hebrew University Medical Center, Jerusalem, Israel
12:30 DENDRITIC-LEUKEMIA CELL HYBRIDS GENERATE SPECIFIC ANTI LEUKEMIA CTLS IN VITRO
R. Eshel 1, M. Shpringer 1, R. Ben-Yosef 2, A. Vexler 2, E. Naparstek 1
1 Bone Marrow Transplantation, Tel-Aviv Sourasky Medical Center, Tel-Aviv Israel; 2 Department of Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv Israel
12:50 LUNCH BREAK
14:00 - 15:40 Dan Panorama - Hall E
PLENARY SESSION VI: EMBRYONIC AND ADULT STEM CELLS
Invited Lectures
Chairpersons:   Karl Skorecki
  Reuven Or
14:00 DISSECTING CELL FATE REGULATION IN STEM CELLS
I. R. Lemischka 1
1 Dept. of Molecular Biology, Princeton University, NJ, USA
14:40 STEM CELL THERAPY IN MODELS OF MULTIPLE SCLEROSIS
T. Ben-Hur 1
1 Department of Neurology, Hadassah University Medical Center, Jerusalem, Israel
15:00 HUMAN OLIGODENDROCYTES FROM EMBRYONIC STEM CELLS: PHENOTYPIC DIFFERENTIATION AND MYELINATING CAPACITY FOLLOWING TRANSPLANTATION
M. Revel 1, M. Izrael 1, P. Zhang 1, J. Itskovitz-Eldor 2, J. Chebath 1
1 Weizmann Institute of Science, Rehovot, Israel; 2 Rambam Medical Center, Haifa, Israel
15:20 USE OF BONE MARROW DERIVED STEM CELLS, LYMPHOCYTES AND MESENCHYMAL CELLS FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT DISEASES AND FOR TISSUE REPAIR
S. Slavin 1, O. Gurevitch 1, B.G. Kurkalli 1, M.Y. Shapira 1, I.B. Resnick 1, M. Bitan 1, R. Or 1, S. Morecki 1, T. Prigozhina 1, D. Karussis 2
1 Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah University Hospital, Jerusalem 91120, Israel; 2 Neurology Department, Hadassah University Hospital, Jerusalem 91120, Israel
15:40 COFFEE BREAK
16:00 - 17:30 Dan Panorama - Hall E
PLENARY SESSION VII: EU STEM CELL RESEARCH
Chairperson:  Eva Rockman
16:00 PRESENT AND FUTURE OF CANCER TREATMENT USING ALLO-IMMUNOTHERAPY
J.A. Madrigal 1
1 The Anthony Nolan Research Institute Royal Free Hospital, London, UK
16:30 FUNCTIONAL GENOMICS IN EMBRYONIC STEM CELLS: GLOBAL AND LINEAGE-SPECIFIC TRANSCRIPTOME ANALYSIS-ACHIEVEMENTS OF THE FUNGESES CONSORTIUM
A. Sachinidis 1
1 Center Of Physiology And Pathophysiology, University Of Cologne, Cologne, Germany
17:00 EU SUPPORT FOR STEM CELL RESEARCH
C. Kessler
1 European Commission, Brussels, Belgium

Back to top

 



Print this page | Back All Days | Day 1 | Day 2 | Day 3
     
©ILSI-BIOMED 2007. All Rights Reserved KENES INTERNATIONAL CONTACT US SITE MAP